MANE insider ownership: who sold, why, and what they still hold

What stands out

Two directors bought shares: John Childs (588K shares, $10.0M) and Vlad Coric (118K shares, $2.0M). These are the first purchases by current officers or directors in the filings on record.John Childs: purchase, Feb 5, 2026 · Vlad Coric: purchase, Feb 5, 2026

John Childs sold $10.7M of stock with no disclosed trading plan. The filings don't state a reason.Largest such sale, Aug 12, 2026

Outside holder MONTANOVA CAPITAL, LLC, a 10% owner and not part of management, sold $80.4M of stock.Largest sale, Aug 19, 2026

A share of stake is shown for 0 of the 3 officers and directors who sold. 12 are left out

Left out: Reid Waldman, Timothy Durso, Vlad Coric, Dominic Carrano, Mark Neumann, Michael Greco, Patrick Enright, John Childs, David Friedman, Jane Grant-Kels, Katarina Pance and David Hollander (share of stake is being verified).

Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Their share of stake is being verified and is not shown yet; amounts and trading plans are below.

John Childs

Director

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$10.7MNo plan disclosed

Reid Waldman

Chief Executive Officer, Director

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$7.3MDisclosed plan

Timothy Durso

Chief Technical Officer

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$4.7MDisclosed plan

Amounts, filings and trading plans for each seller

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled

Recent activity

Past 30 days, Sep 14, 2026 to Oct 13, 2026

No officer or director trades were reported for the past 30 days. The most recent before that:

Aug 17, 20262 executives sold 111K shares ($12.0M) under a disclosed trading plan. 6.9K shares came in from vesting or option exercises the same day, so their combined holdings fell by 104K net.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Reid Waldman Chief Executive Officer, Director	67,500	$107.86	n/a	n/a	Aug 17, 2026	Aug 18, 2026
Timothy Durso Chief Technical Officer	43,500	$107.82	n/a	n/a	Aug 17, 2026	Aug 18, 2026

Outside holders, reported separately

MONTANOVA CAPITAL, LLC sold $80.4M in the past 12 months. Large shareholders and the funds or companies that board members represent are not part of management, so they are left out of the figures above.

Details

Common questions

Is the Veradermics, Inc CEO selling stock?

Yes. Reid Waldman sold 68K shares ($7.3M) in the past 12 months, all of it under a trading plan disclosed in the filings.

Why are Veradermics, Inc insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 53% of sales by value ran under 10b5-1 trading plans disclosed in the filings and 47% had no disclosed plan. A trading plan schedules sales in advance.

Are any Veradermics, Inc insiders buying?

Yes. 2 officers or directors reported 4 purchases in the past 12 months (Form 4 code P; rows the filings describe as reinvested dividends, plan purchases, private deals or moves into the person's own trust are not counted).

The evidence

Who sold3 officers and directors: amount, % of holdings, trading plan

Who sold	Amount	% of holdings	Trading plan
John Childs Director	$10.7M 100K shares	Not confirmed share of stake is being verified. Why	No plan disclosed
Reid Waldman Chief Executive Officer, Director	$7.3M 68K shares	Not confirmed share of stake is being verified. Why	Disclosed plan
Timothy Durso Chief Technical Officer	$4.7M 44K shares	Not confirmed share of stake is being verified. Why	Disclosed plan

Board members representing outside shareholders, reported separately: Patrick Enright. Details

Outside holder, reported separately: MONTANOVA CAPITAL, LLC (an outside shareholder, not part of management). Sold $80.4M (750K shares) from Aug 19, 2026 to Aug 19, 2026. Latest filing

Outside holder, reported separately: Seven Fleet Capital Management LP (a 10% owner, not part of management). No open-market sales reported in the period. Latest filing

Outside holder, reported separately: Longitude Capital Partners V, LLC (a 10% owner, not part of management). No open-market sales reported in the period. Latest filing

The full ownership picture0 of 12 officers and directors confirmed

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

Insider

Held Oct 13, 2025

Sold

Held Oct 13, 2026

Still held

Reid Waldman

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Reid Waldman are complete.

Chief Executive Officer, Director

n/a

−68K

n/a

Vesting, gifts, unvested awards and holding lines for Reid Waldman

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Reid Waldman are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
84,504	$12.19	Dec 12, 2031	$8.0M
5,343	$12.19	Dec 21, 2032	$508K
9,864	$12.19	Mar 18, 2029	$938K
5,035	$12.19	Mar 18, 2034	$479K
224,247	$12.19	Feb 26, 2035	$21.3M
1,039,490	$12.79	Nov 13, 2035	$98.2M
243,984	$12.79	Nov 13, 2035	$23.0M
556,399	$17.00	Feb 3, 2036	$50.2M

Estimate: options held × ($107.25 − strike price), using the most recent insider trade price on Form 4 (Aug 19, 2026), not a market close.

Timothy Durso

Chief Technical Officer

n/a

−44K

n/a

Vesting, gifts, unvested awards and holding lines for Timothy Durso

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Timothy Durso are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
3,542	$12.19	Dec 12, 2026	$337K
84,504	$12.19	Dec 12, 2031	$8.0M
5,343	$12.19	Dec 21, 2032	$508K
9,864	$12.19	Mar 18, 2029	$938K
5,035	$12.19	Mar 18, 2034	$479K
89,699	$12.19	Feb 26, 2035	$8.5M
356,689	$12.79	Nov 13, 2035	$33.7M
121,992	$12.79	Nov 13, 2035	$11.5M
213,352	$17.00	Feb 3, 2036	$19.3M

Estimate: options held × ($107.25 − strike price), using the most recent insider trade price on Form 4 (Aug 19, 2026), not a market close.

Vlad Coric

Director

n/a

Vesting, gifts, unvested awards and holding lines for Vlad Coric

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Vlad Coric are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
4,764	$12.19	Nov 2, 2032	$453K
51,525	$17.00	Feb 3, 2036	$4.7M

Estimate: options held × ($107.25 − strike price), using the most recent insider trade price on Form 4 (Aug 19, 2026), not a market close.

Dominic Carrano

Chief Financial Officer

n/a

Vesting, gifts, unvested awards and holding lines for Dominic Carrano

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Dominic Carrano are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
15,951	$12.19	Oct 5, 2033	$1.5M
249	$12.19	Mar 18, 2034	$24K
53,819	$12.19	Feb 26, 2035	$5.1M
215,887	$12.79	Nov 13, 2035	$20.4M
42,886	$12.79	Nov 13, 2035	$4.1M
148,011	$17.00	Feb 3, 2036	$13.4M

Estimate: options held × ($107.25 − strike price), using the most recent insider trade price on Form 4 (Aug 19, 2026), not a market close.

Mark Neumann

Chief Commercial Officer

n/a

Vesting, gifts, unvested awards and holding lines for Mark Neumann

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Mark Neumann are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
264,206	$12.79	Dec 15, 2035	$25.0M
39,630	$12.79	Dec 15, 2035	$3.7M
102,885	$17.00	Feb 3, 2036	$9.3M

Estimate: options held × ($107.25 − strike price), using the most recent insider trade price on Form 4 (Aug 19, 2026), not a market close.

Michael Greco

General Counsel

n/a

Vesting, gifts, unvested awards and holding lines for Michael Greco

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Michael Greco are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
94,273	$12.19	Nov 13, 2035	$9.0M
145,140	$12.79	Nov 13, 2035	$13.7M
35,912	$12.79	Nov 13, 2035	$3.4M
144,401	$17.00	Feb 3, 2036	$13.0M

Estimate: options held × ($107.25 − strike price), using the most recent insider trade price on Form 4 (Aug 19, 2026), not a market close.

Patrick Enright

Director

n/a

Vesting, gifts, unvested awards and holding lines for Patrick Enright

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Patrick Enright are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
45,131	$17.00	Feb 3, 2036	$4.1M

Estimate: options held × ($107.25 − strike price), using the most recent insider trade price on Form 4 (Aug 19, 2026), not a market close.

John Childs

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. See the filing Sales and other transactions for John Childs are complete.

Director

n/a

−100K

n/a

Vesting, gifts, unvested awards and holding lines for John Childs

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for John Childs are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
51,525	$17.00	Feb 3, 2036	$4.7M

Estimate: options held × ($107.25 − strike price), using the most recent insider trade price on Form 4 (Aug 19, 2026), not a market close.

David Friedman

Director

n/a

Vesting, gifts, unvested awards and holding lines for David Friedman

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for David Friedman are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
43,000	$17.00	Feb 3, 2036	$3.9M

Estimate: options held × ($107.25 − strike price), using the most recent insider trade price on Form 4 (Aug 19, 2026), not a market close.

Jane Grant-Kels

Director

n/a

Vesting, gifts, unvested awards and holding lines for Jane Grant-Kels

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Jane Grant-Kels are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
51,525	$17.00	Feb 3, 2036	$4.7M

Estimate: options held × ($107.25 − strike price), using the most recent insider trade price on Form 4 (Aug 19, 2026), not a market close.

Katarina Pance

Director

n/a

Vesting, gifts, unvested awards and holding lines for Katarina Pance

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Katarina Pance are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
43,000	$17.00	Feb 3, 2036	$3.9M

Estimate: options held × ($107.25 − strike price), using the most recent insider trade price on Form 4 (Aug 19, 2026), not a market close.

David Hollander

Chief R&D Officer

n/a

Vesting, gifts, unvested awards and holding lines for David Hollander

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for David Hollander are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
19,300	$97.51	Sep 1, 2036	$188K

Estimate: options held × ($107.25 − strike price), using the most recent insider trade price on Form 4 (Aug 19, 2026), not a market close.

Holdings and share of stake for Veradermics, Inc are being verified, so no balances, unit counts or percentages are shown. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings.

What explains the selling$22.7M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $22.7M across 211,000 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

Disclosed plan · $12.0M · 53%

47%

The lighter segment is sales with no plan disclosed in the filing ($10.7M), including tax-related sales outside a plan.

No plan disclosed · $10.7M

Sales with no 10b5-1 plan and no tax reference in the filing. $10.7M of it is John Childs. No plan disclosed is a statement about the filing, not about why the sale happened. Largest such sale: John Childs, Aug 12, 2026

Purchases · 2 buyers (4 trades)

2 officers and directors bought shares in this period, in 4 trades(Form 4 code P, leaving out rows the filings describe as reinvested dividends, plan purchases, private deals or moves into the person's own trust). Across all their filings on record there are 4 purchase trades.

Seller	Shares sold	Proceeds	Under a disclosed plan	Share of total	Sales dates
John Childs Director	100K	$10.7M	0%	47%	Aug 12, 2026 to Aug 12, 2026
Reid Waldman Chief Executive Officer, Director	68K	$7.3M	100%	32%	Aug 17, 2026 to Aug 17, 2026
Timothy Durso Chief Technical Officer	44K	$4.7M	100%	21%	Aug 17, 2026 to Aug 17, 2026

Sales by month

Month	Sale proceeds	Disclosed plan	To cover taxes	No plan disclosed
Oct 2025	$0	$0	$0	$0
Nov 2025	$0	$0	$0	$0
Dec 2025	$0	$0	$0	$0
Jan 2026	$0	$0	$0	$0
Feb 2026	$0	$0	$0	$0
Mar 2026	$0	$0	$0	$0
Apr 2026	$0	$0	$0	$0
May 2026	$0	$0	$0	$0
Jun 2026	$0	$0	$0	$0
Jul 2026	$0	$0	$0	$0
Aug 2026	$22.7M	$12.0M	$0	$10.7M
Sep 2026	$0	$0	$0	$0
Oct 2026	$0	$0	$0	$0

Board members representing outside shareholders (1)Listed and sourced; not part of the management totals or the answer line

Directors whose reported holdings sit mostly in an investment fund or a corporate shareholder they represent, not in their own name, with beneficial ownership disclaimed except for their own financial interest. Listed and sourced here; not part of the management totals or the answer line. Shares a fund hands to its own investors are distributions, not sales.

Board member	Held Oct 13, 2025	Sold	Held Oct 13, 2026	Still held
Patrick Enright ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Patrick Enright are complete. Director	n/a	0	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Patrick Enright Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Patrick Enright are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts)

Known gaps and uncertainty12 officers and directors not confirmed

Holdings and share of stake are being verified. Balances, unit counts and every share-of-stake figure for Veradermics, Inc are held back until that check is finished. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings and are complete.

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology35 filings on record, 35 filed in the 12-month period, and how we read them

All 35 Forms 3, 4 and 5 on record for Veradermics, Inc (SEC CIK 1827635), filed from Feb 3, 2026 to Sep 3, 2026; 35 of them were filed in the 12 months this page covers, retrieved from SEC EDGAR on Oct 13, 2026. Prices are the ones reported in each filing, often weighted averages.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.

Veradermics, Inc insiders sold $22.7M in the past 12 months. How much of their stake is that?

What stands out

Who sold, and how much of their stake

Selling by month

Recent activity

Outside holders, reported separately

Common questions

Is the Veradermics, Inc CEO selling stock?

Why are Veradermics, Inc insiders selling?

Are any Veradermics, Inc insiders buying?

The evidence

No plan disclosed · $10.7M

Purchases · 2 buyers (4 trades)

Sales by month